Pfizer Far Less Effective For Delta Variant Than Earlier Coronavirus Strains: Lancet Study

Pfizer Far Less Effective For Delta Variant Than Earlier Coronavirus Strains: Lancet Study

The study also shows that levels of these antibodies that are able to recognise and fight the virus are lower with increasing age, and that levels decline over time, providing additional evidence in support of plans to deliver a booster dose to vulnerable people
Coronavirus Outbreak, Coronavirus Vaccine, News
- in Coronavirus Outbreak, Coronavirus Vaccine, News
0
Pfizer Far Less Effective For Delta Variant Than Earlier Coronavirus Strains: Lancet StudyThe study analysed antibodies in the blood of 250 healthy people who received the Pfizer vaccine
Highlights
  • Delta variant was first identified in India
  • Study tested ability of antibodies to block entry of the virus into cells
  • This virus will likely be around for some time to come: Expert

London: People fully vaccinated with the Pfizer-BioNTech vaccine are likely to have more than five times lower levels of neutralising antibodies against the Delta variant first identified in India compared to the original strain, according to research published in The Lancet journal. The study also shows that levels of these antibodies that are able to recognise and fight the virus are lower with increasing age, and that levels decline over time, providing additional evidence in support of plans to deliver a booster dose to vulnerable people.

Also Read: Coronavirus Explained: All You Need To Know About The COVID-19 Vaccine For Children In India

It supports current plans in the UK to reduce the dose gap between vaccines since they found that after just one dose of the Pfizer-BioNTech vaccine, people are less likely to develop antibody levels against the B.1.617.2 variant as high as those seen against the previously dominant B.1.1.7 (Alpha) variant, first found in Kent.

The team, led by researchers from the Francis Crick Institute in the UK, noted that levels of antibodies alone do not predict vaccine effectiveness and prospective population studies are also needed. Lower neutralising antibody levels may still be associated with protection against COVID-19, they said.

The study analysed antibodies in the blood of 250 healthy people who received either one or two doses of the Pfizer-BioNTech Covid-19 vaccine, up to three months after their first dose.

The researchers tested the ability of antibodies to block entry of the virus into cells, so called ‘neutralising antibodies’, against five different variants of SARS-CoV-2.

They then compared concentrations of these neutralising antibodies between all variants.

Data from previous clinical studies suggests that higher antibody titres or concentration is a good predictor of vaccine efficacy and greater protection against COVID-19.

The researchers found that in people who had been vaccinated with two doses of the Pfizer-BioNTech vaccine, levels of neutralising antibodies were more than five times lower against the B.1.617.2 variant when compared to the original strain, upon which current vaccines are based.

Also Read: COVID-19 Vaccine Explainer: How Do Vaccines Work?

This antibody response was even lower in people who had only received one dose, they said.

After a single dose of Pfizer-BioNTech, 79 per cent of people had a quantifiable neutralising antibody response against the original strain, but this fell to 50 per cent for B.1.1.7, 32 per cent for B.1.617.2 and 25 per cent for B.1.351 or Beta variant first discovered in South Africa.

While antibody levels decreased with age against all variants, no correlation was observed for sex or body mass index (BMI).

This virus will likely be around for some time to come, so we need to remain agile and vigilant, said Emma Wall, an Infectious Diseases consultant at University College London Hospitals NHS Foundation Trust (UCLH).

Our study is designed to be responsive to shifts in the pandemic so that we can quickly provide evidence on changing risk and protection, Ms Wall said.

The researchers noted that the most important thing is to ensure that vaccine protection remains high enough to keep as many people out of hospital as possible.The study suggests that the best way to do this is to quickly deliver second doses and provide boosters to those whose immunity may not be high enough against these new variants, they said.

Also Read: COVID-19: UK Regulator Approves Pfizer/Biontech Vaccine For 12-15-Year-Olds

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

NDTV – Dettol Banega Swasth India campaign is an extension of the five-year-old Banega Swachh India initiative helmed by Campaign Ambassador Amitabh Bachchan. It aims to spread awareness about critical health issues facing the country. In wake of the current COVID-19 pandemic, the need for WASH (WaterSanitation and Hygiene) is reaffirmed as handwashing is one of the ways to prevent Coronavirus infection and other diseases. The campaign highlights the importance of nutrition and healthcare for women and children to prevent maternal and child mortality, fight malnutrition, stunting, wasting, anaemia and disease prevention through vaccines. Importance of programmes like Public Distribution System (PDS), Mid-day Meal Scheme, POSHAN Abhiyan and the role of Aganwadis and ASHA workers are also covered. Only a Swachh or clean India where toilets are used and open defecation free (ODF) status achieved as part of the Swachh Bharat Abhiyan launched by Prime Minister Narendra Modi in 2014, can eradicate diseases like diahorrea and become a Swasth or healthy India. The campaign will continue to cover issues like air pollutionwaste managementplastic banmanual scavenging and sanitation workers and menstrual hygiene

World

19,66,15,634Cases
6,33,31,644Active
12,90,85,240Recovered
41,98,750Deaths
Coronavirus has spread to 194 countries. The total confirmed cases worldwide are 19,66,15,634 and 41,98,750 have died; 6,33,31,644 are active cases and 12,90,85,240 have recovered as on July 30, 2021 at 4:07 am.

India

3,15,72,344 44,230Cases
4,05,155 1,315Active
3,07,43,972 42,360Recovered
4,23,217 555Deaths
In India, there are 3,15,72,344 confirmed cases including 4,23,217 deaths. The number of active cases is 4,05,155 and 3,07,43,972 have recovered as on July 30, 2021 at 2:30 am.

State Details

State Cases Active Recovered Deaths
Maharashtra

62,90,156 7,242

81,933 3,980

60,75,888 11,032

1,32,335 190

Kerala

33,49,365 22,064

1,55,327 5,287

31,77,453 16,649

16,585 128

Karnataka

29,01,247 2,052

23,277 685

28,41,479 1,332

36,491 35

Tamil Nadu

25,55,664 1,859

21,207 314

25,00,434 2,145

34,023 28

Andhra Pradesh

19,62,049 2,107

21,279 280

19,27,438 1,807

13,332 20

Uttar Pradesh

17,08,373 60

784 16

16,84,834 44

22,755

West Bengal

15,26,539 766

11,300 70

14,97,116 822

18,123 14

Delhi

14,36,144 51

554 19

14,10,541 70

25,049

Chhattisgarh

10,01,781 130

2,086 140

9,86,175 270

13,520

Odisha

9,74,132 1,615

15,276 489

9,53,088 2,039

5,768 65

Rajasthan

9,53,622 17

259 9

9,44,410 26

8,953

Gujarat

8,24,829 27

268 6

8,14,485 33

10,076

Madhya Pradesh

7,91,796 18

130 0

7,81,153 18

10,513

Haryana

7,69,858 30

712 10

7,59,516 17

9,630 3

Bihar

7,24,719 46

481 1

7,14,596 42

9,642 3

Telangana

6,43,716 623

9,188 126

6,30,732 746

3,796 3

Punjab

5,99,005 58

553 6

5,82,162 60

16,290 4

Assam

5,64,030 1,299

14,114 385

5,44,695 1,664

5,221 20

Jharkhand

3,47,105 56

259 22

3,41,720 34

5,126

Uttarakhand

3,41,982 48

669 3

3,33,952 51

7,361

Jammu And Kashmir

3,21,207 181

1,144 5

3,15,686 175

4,377 1

Himachal Pradesh

2,05,728 229

1,098 145

2,01,110 84

3,520

Goa

1,70,900 90

1,077 5

1,66,679 93

3,144 2

Puducherry

1,20,725 98

972 49

1,17,961 49

1,792

Manipur

96,824 1,000

10,895 27

84,408 1,016

1,521 11

Tripura

78,059 271

3,640 221

73,665 488

754 4

Meghalaya

63,745 731

5,750 294

56,933 423

1,062 14

Chandigarh

61,948 5

37 1

61,102 4

809

Arunachal Pradesh

47,477 335

4,252 49

43,000 383

225 1

Mizoram

37,171 764

11,862 252

25,168 511

141 1

Nagaland

27,653 67

1,299 51

25,798 114

556 4

Sikkim

26,132 276

3,297 180

22,498 92

337 4

Ladakh

20,324 4

60 4

20,057 8

207

Dadra And Nagar Haveli

10,643 1

36 5

10,603 6

4

Lakshadweep

10,162 7

70 6

10,042 13

50

Andaman And Nicobar Islands

7,534 3

10 3

7,395

129

Coronavirus Outbreak: Full CoverageTesting CentresFAQs

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like

Delta Variant Of COVID-19 May Spread As Easily As Chickenpox, Cause More Severe Infection: Reports

COVID-19 Delta Variant: The document from the Centers for Disease Control and Prevention (CDC) outlines unpublished data that shows fully vaccinated people might spread the Delta variant, first identified in India, at the same rate as unvaccinated people, reports said